The present invention relates to a composition for preventing or treating benign prostatic hyperplasia disease, the composition comprising, as active ingredients, extracts of Semen cuscutae, Semen nelumbinis, and Taraxacum platycarpum. When using the present invention, it is possible to effectively prevent or treat benign prostatic hyperplasia without side effects.

The present invention relates to a composition for preventing or treating benign prostatic hyperplasia disease, the composition comprising, as active ingredients, extracts of Semen cuscutae, Semen nelumbinis, and Taraxacum platycarpum. When using the present invention, it is possible to effectively prevent or treat benign prostatic hyperplasia without side effects.

The present invention relates to a composition for preventing or treating benign prostatic hyperplasia disease, the composition comprising, as active ingredients, extracts of Semen cuscutae, Semen nelumbinis, and Taraxacum platycarpum. When using the present invention, it is possible to effectively prevent or treat benign prostatic hyperplasia without side effects.

An eye-soothing externally-applied liquid medicine includes a phase A, a phase B, an adjuvant and purified water. The phase A includes a western medicine component and a traditional Chinese medicine component by mass. The western medicine component includes at least one of 0.1 g of atropine, 0,1 g of homatropine, and 0.1 g of tropicamide. The traditional Chinese medicine component includes at least one of 0.5 g of a cassia seed extract, 0.5 g of a mulberry leaf extract, 0.2 g of a marigold flower extract, 0.5 g of a fibs albiziae extract, 0.5 g of an eyebright extract, and 0.2 g of a common foxglove leaf extract. The phase B includes 1 g of vitamin A, 0.5 g of vitamin B1, 0.005 g of vitamin B2, 0.001 g of vitamin B12, 0.5 g of adenosine triphosphate, 1 g of vaccinium myrtillus seed oil, and 0.001 g of lutein.

An eye-soothing externally-applied liquid medicine includes a phase A, a phase B, an adjuvant and purified water. The phase A includes a western medicine component and a traditional Chinese medicine component by mass. The western medicine component includes at least one of 0.1 g of atropine, 0,1 g of homatropine, and 0.1 g of tropicamide. The traditional Chinese medicine component includes at least one of 0.5 g of a cassia seed extract, 0.5 g of a mulberry leaf extract, 0.2 g of a marigold flower extract, 0.5 g of a fibs albiziae extract, 0.5 g of an eyebright extract, and 0.2 g of a common foxglove leaf extract. The phase B includes 1 g of vitamin A, 0.5 g of vitamin B1, 0.005 g of vitamin B2, 0.001 g of vitamin B12, 0.5 g of adenosine triphosphate, 1 g of vaccinium myrtillus seed oil, and 0.001 g of lutein.

Use of an immune modulator composition and/or pharmaceutical composition comprising Guanidinium Derivatives substances for use in the manufacture of a medicament for the treatment of an autoimmune disease or autoimmune disorder, including certain vascular disorders. Immunity-inducing agent composition having a pH of between 5.5 and 7.5 containing at least 100 mg/l, preferably at least 300 mg/l of a combination food protecting agent and guanidinium derivatives, particularly to combinations of oligo(2-(2-ethoxy)ethoxy ethyl guanidinium chloride), poly(hexamethylendiamine guanidiniumchloride), polyetheramines, triethyleneglycol diamine, mushrooms, enzymes, PGPR, amino acids, antioxidants like humic acids and some natural products like phytotherapeutic plant extracts.

Use of an immune modulator composition and/or pharmaceutical composition comprising Guanidinium Derivatives substances for use in the manufacture of a medicament for the treatment of an autoimmune disease or autoimmune disorder, including certain vascular disorders. Immunity-inducing agent composition having a pH of between 5.5 and 7.5 containing at least 100 mg/l, preferably at least 300 mg/l of a combination food protecting agent and guanidinium derivatives, particularly to combinations of oligo(2-(2-ethoxy)ethoxy ethyl guanidinium chloride), poly(hexamethylendiamine guanidiniumchloride), polyetheramines, triethyleneglycol diamine, mushrooms, enzymes, PGPR, amino acids, antioxidants like humic acids and some natural products like phytotherapeutic plant extracts.

A traditional Chinese medicine composition includes 60%-80% by weight of Eucommia ulmoides extract, 15%-30% by weight of Rhizoma Drynariae extract and 5%-10% by weight of Semen Cuscutae extract. A method of preparing the traditional Chinese medicine composition is also provided. Uses of the traditional Chinese medicine composition in the prevention and/or treatment of osteoporosis are also provided.

A traditional Chinese medicine composition includes 60%-80% by weight of Eucommia ulmoides extract, 15%-30% by weight of Rhizoma Drynariae extract and 5%-10% by weight of Semen Cuscutae extract. A method of preparing the traditional Chinese medicine composition is also provided. Uses of the traditional Chinese medicine composition in the prevention and/or treatment of osteoporosis are also provided.

The present invention discloses the functional drink and method for preparing the same, which is characterized in that: it is made of the main raw materials with the following weight ratios: Deerhorn Glue of 5-8 kg, Rehmannia Glutinosa Libosch of 0.4-0.7 kg, Radix Rehmanniae Preparata of 0.4-0.7 kg, Chinese Angelica of 0.4-0.7 kg, Herba Cistanches of 0.4-0.7 kg, Cuscuta Europaea of 0.4-0.7 kg, Ganoderma Lucidum of 1.8-4 kg, Largehead Atractylodes Rhizome of 0.7 kg, Ligustrum Lucidum of 0.5-0.8 kg, Tortoise Carapace and Plastron of 0.5-0.8 kg, Astragali Radix of 0.6 kg, Fructo-oligosaccharide of 7-9 kg and drinking water of 82.2 L; the Jun (emperor) medicinal herbs used in the present invention have the effect of tonifying the kidney and nourishing the essence of blood, and the Chen (minister) medicinal herbs have the effect of regulating bodily functions, and the Zuo (adjuvant) and Shi (courier) medicinal herbs have the effects of adjusting Qi and blood and coordinating various medicines.